following the Bank of Thailand’s requirements and evaluate the profile of debtors based on the bank’s historical data. The bank has set aside of reserves for bad debts, doubtful accounts and impairment loss
and cash equivalents in the amount of THB 450.39 million. This was pursuant to the Company’s policy in maintaining liquidity and setting aside cash reserves to be used as working capital in order to
projection late last year. The ratio of non- performing loan (NPL) to total loans was 4.1 percent. The ratio of loan loss reserves to NPL was 170.5 percent. The Bank continues to work closely side by side and
จดัการ (อังกฤษ) : TISCO Biotechnology Healthcare Fund 1.3. ช่ือยอ่ : TBIOTECH 1.4. ประเภทโครงการ : กองทุนเปิด 1.5. ประเภทการขาย : ขายหลายครั้ง 1.6. การก าหนดอายุโครงการ : ไม่ก าหนด 1.7. อายุโครงการ : ปี
องทนุรวม : 1.1. ชือ่โครงกำรจัดกำร (ไทย) : กองทนุเปิด ทสิโก ้ไบโอเทคโนโลย ีเฮลธแ์คร ์ 1.2. ชือ่โครงกำรจัดกำร (องักฤษ) : TISCO Biotechnology Healthcare Fund 1.3. ชือ่ยอ่ : TBIOTECH 1.4. ประเภทโครงกำร
% - Legal reserves 19,700 0% 32,700 1% 32,700 0% 32,700 1% - Unappropriated (Deficit) 361,999 7% 515,258 8% 302,505 4% (641,293) -10% Total equity 2,978,522 59% 3,883,413 62% 3,681,683 51% 2,746,683 42% Total
liabilities 187,661 67% 194,129 76% 37,532 15% Share capital 170,000 61% 170,000 67% 340,000 139% Retained earnings (Deficit) - 0% - 0% - 0% - Legal reserves - 0% - 0% - 0% - Unappropriated (Deficit) (78,869
to the allowances for bad debt and doubtful accounts of the bank are adequate as seen from high proportion of loan loss reserves ratio is at 186.65%. Earnings per share for the second quarter and the
decreased by 37.4% and bad debt and doubtful accounts decreased by 42.6% due to the allowances for bad debt and doubtful accounts of the bank are adequate as seen from high proportion of loan loss reserves
reserves ratio is at 184.32%. Earnings per share for the third quarter and the nine-month period of 2017 were Baht 0.04 per share and Baht 0.12 per share, respectively. When compared to the third quarter and